Abstract A nationwide investigation of congenital malformations and genetic diseases in Korea was conducted by analyzing Medical Insurance data for infants aged under 1 year. Medical Insurance data were obtained for 1993 and 1994 and the ICD-9 (International Classification of Diseases, Ninth Revision) code was used to classify the diseases. The coverage rate of medical insurance was approximately 95% of the total population. Anomalies of the cardiovascular, musculoskeletal, and gastrointestinal systems, in descending order of frequency, were more frequent than anomalies in other systems. The average prevalence of cardiovascular anomalies for 1993 and 1994 was 15 per 1000 infants, and ventricular septal defect, with an average prevalence of about 3.50 per 1000 for 1993 and 1994, was the most frequent cardiovascular anomaly in infants. Polydactyly was the most frequent musculoskeletal anomaly, with an average prevalence, for 1993 and 1994, of about 1.20 per 1000 infants. Anencephaly had the highest frequency of nervous system anomalies. Congenital hypertrophic pyloric stenosis was the most common of the gastrointestinal anomalies. The prevalence of the congenital malformations and genetic diseases examined was similar to that reported in other countries. Total medical expenses for the care of patients with each disease entity were also estimated. The highest medical expenses were incurred for ventricular septal defect, congenital coagulation factor VIII disorders, atrial septal defect, tetralogy of Fallot, and spinal anomalies, in descending order of magnitude. This investigation could be helpful in planning social welfare systems, as well as for elucidating the current status of congenital malformations and genetic diseases in Korea, and in other Asian countries.
Introduction
In all countries, the priorities for medical approaches to genetic diseases depend upon the local frequencies of those diseases, the health care burden that they represent, the possibilities for prevention and treatment, available resources, and the health care infrastructure. Congenital malformations and genetic diseases can be of varying degrees of severity, may have, at onset, any degree of severity, and the onset may be at any stage in the patients lifetime. However, those diseases in which symptoms are presented at birth are particularly burdensome, because they may cause early death or lifelong disability. Investigation on the prevalence of genetic diseases is important not only as a matter of medical interest but also for the planning of social welfare systems. In developed countries, congenital and genetic disorders are the second most common cause of death in infancy and childhood (Forfar 1992) , and in those countries the incidence of births of infants with congenital disorders, including disorders that are regarded as trivial or relatively easily corrected (such as Congenital hypertrophic pyloric stemosis and polydoctyly), is about 25-60 per 1000 (WHO Scientific Group 1996) . Approximately 20% of all conceptions result in fetuses that have a chromosomal disorder, but most of these fail to implant or are spontaneously aborted, so that the birth frequency of infants with chromosomal disorders is 0.6% (Connor and Ferguson-Smith 1997) .
There have been reports of congenital malformations and genetic diseases in Korea, but, as most of them were based on data from single hospitals or limited areas, they could not represent the status of genetic diseases in the country as a whole. Therefore, we investigated nationwide medical insurance data and analyzed these data to elucidate the current status of congenital malformations and genetic diseases in Korea.
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Prevalence of congenital malformations and genetic diseases in Korea Subjects and methods
Medical insurance benefit data from the Korean Federation of Medical Insurance were examined for 1993 and 1994. The coverage rate of medical insurance was approximately 95% of the total population. The medical insurance benefit data originally included all medical activities for diagnosis and treatment. Information on the insurance society, type of medical care institution, episodes of hospital admission, national identification number, birthday, day of first visit, days of visits, major disease code, and total expenses was collected. We used the International Classification of Diseases, Ninth Revision (ICD-9) to classify genetic diseases and congenital malformations. For congenital anomalies, ICD-9 codes 740.0-759.9 were investigated, except for the chromosomal anomalies (ICD-9, 758.0-758.9). All candidate codes for single gene disorders and other congenital anomalies that were not included in ICD-9 codes 740.0-759.9 were also investigated. The disease data were analyzed according to the four-digit subcategory of ICD-9. To avoid double registration of a patient, spell-based data were converted to person-based by national identification number and disease code. Therefore patients with multiple anomalies could be counted separately with different disease codes. Data from pharmacies, dental clinics, and oriental medical clinics were excluded because of the unreliability of diagnosis. Prevalences were calculated using the number of infants below age 1 year among medical insurance dependants as the denominator. To estimate medical expenses for the care of patients with congenital malformations and genetic diseases, insurance benefits and patient-charged consultation fees were also investigated.
Results
Medical insurance covered approximately 95% of the total Korean population in 1993 and 1994 . Of the population of infants aged under 1 year, 601,376 were covered by medical insurance in 1993 and 601,459 in 1994. The overall prevalence of congenital malformations per 1000 infants aged less than 1 year was 39.3 in 1993 and 34.4 in 1994. Cardiovascular anomalies were the most common congenital malformations in infants. The second most common were musculoskeletal anomalies, with the third most common, gastrointestinal anomalies. The prevalence of cardiovascular anomalies was 15.6 per 1000 infants in 1993 and 14.0 in 1994 (Table 1) .
Anencephaly was the most frequent congenital anomaly of the nervous system (Table 2) , with a prevalence of 0.26 per 1000 infants in 1993 and 0.42 in 1994. The prevalence of spina bifida was also high (0.30 per 1000 infants in 1993 and 0.27 in 1994) among nervous system anomalies. The most frequent cardiovascular anomaly was ventricular septal defect, and its prevalence per 1000 infants was 3.59 in 1993 and 3.24 in 1994. Pulmonary valve anomalies were the second most common cardiovascular anomaly, followed by, 1993, 0.11 in 1994) . Total medical expenses for the care of patients with each congenital malformation and genetic disease entity were relatively high. The greatest expenses incurred were for ventricular septal defect, congenital coagulation factor VIII disorders, atrial septal defect, tetralogy of Fallot, and spinal anomalies, in descending order of magnitude. Total medical expenses for patients with ventricular septal defect were about 7 billion Korean won (US $ 7,778,000), and for patients with congenital coagulation factor VIII disorders, about 5 billion Korean won (US $ 5,556,000), in 1993. The order was similar in 1994, but the expenses were slightly lower (Table 8) .
Discussion
In evaluating the epidemiological study of congenital malformations, different methods of case ascertainment can give rise to considerable variability in estimating prevalence; this is a significant problem worldwide. The reported prevalence of congenital malformations ranges from 30 to 50 per 1000 births, depending on study methods and diagnostic criteria. Our study was not based on medical record review but on medical insurance benefit data. These data had several limitations. The case ascertainment was relatively incomplete, because some disease codes for these data were based on tentative diagnoses. The disease data were analyzed by four-digit subcategory of ICD-9, but a proportion of disease records had been reported with the wrong code, which was not included in the ICD-9 system; we assumed this was because of input or recording error. In these cases we regarded the record as being included in the corresponding three-digit category; therefore, the fre- quency and prevalence of diseases in our report by the fourdigit subcategory were somewhat underestimated.
The overall prevalence of congenital anomalies in our study was similar to that reported in other studies in Korea (Chi 1987 , Park et al. 1993 ). The prevalence of anencephaly was lower than that reported in Los Angeles County, USA (Sever 1982) and Osaka city, Japan (Imaizumi et al. 1991) . The estimated prevalence of neural tube defects, including anencephaly, spina bifida, and encephalocele, was 0.67-0.77 per 1000 infants, which was very much lower than that in other countries (Congenital Malformations Worldwide, International Clearinghouse 1991) . The prevalence of ventricular septal defect was higher than that in the United States (Ferencz 1990 , Gillum 1994 , Grabitz et al. 1988 , but the frequencies of other cardiovascular anomalies were similar to those in other countries (Connor and FergusonSmith 1997, Hanna et al. 1994) . Congenital hydrocephalus was less common than in Utah, United States (Blackburn and Fineman 1994) ; however, our prevalence data may have been underestimated, as many cases of congenital hydrocephalus were counted as neural tube defects in our medical insurance data. The prevalence of cleft lip and cleft palate was similar to that in western countries (Farhud et al. 1986, Connor and Ferguson-Smith 1997) . Among Asian countries, Japan (Natsume et al. 1987 ) also showed a similar prevalence (2.06 per 1000 births), but China (Xiao 1989) and Singapore (Thein et al. 1992) showed slightly lower figures (1.82 and 1.72 per 1000 births apiece). The prevalence of congenital hypertrophic pyloric stenosis was similar to that in New York, United States, and other countries (Applegate and Druschel 1995) . Hirschprung's disease and diaphragmatic anomalies, including congenital diaphragmatic hernia, were less common than in the United States (Goldberg 1984 , Cannon et al. 1996 .
We also invetigated the prevalences of single gene disorders. The prevalence of adrenogenital disorders was higher than that reported in Sweden (Thilen and Larsson 1990) . The rate of congenital factor VIII disorders was similar to that in other countries (Mosher 1996) .
We studied medical expenses for the care of patients with each disease category in order to investigate the health care load of congenital malformations and genetic diseases borne by Korean society. In 1993, the total medical expense for congenital anomalies (ICD-9, 740.0-759.9) was 36 billion Korean won (US$ 40 million). Although this figure ranked fourteenth among 18 disease categories in descending order of magnitude of expense, it ranked second in order of expenses per claim in 1993 (Korean National Federation of Medical Insurance 1993). These results indicate the burden of these diseases to society as a whole, as well as to the patient and the carer.
This study was the first nationwide investigation of genetic diseases in Korea, but to obtain clearly ascertained cases we are planning to establish a registry system for several congenital malformations and genetic disorders, via the Internet (http://www.nih.go.kr). We are also planning a validity study of medical insurance benefit data by retrieving medical records of sampled hospitals. These studies could be very helpful for elucidating the status of congenital malformations and genetic diseases in other Asian countries, as well as in Korea. 
